Gpt Healthcare Limited · NSE:GPTHEALTH
Gpt Healthcare — Q4 FY2025 Earnings Presentation
30 slides from Gpt Healthcare's earnings presentation, May 23, 2025
Slide 1: GPT Healthcare Limited
GPT Healthcare Limited Regd. Office: GPT Centre, JC-25, Sector III, Salt Lake, Kolkata – 700 106, India CIN : L70101WB1989PLC047402 Phone : +91-33-4050-7000, Email : info@gptgroup.co.in , Visit us: www.gptgroup.co.in GPTHEALTH/CS/SE/2025-26 May 23, 2025 The Department of Corporate Services National
Slide 2: Investor Presentation – Q4 & FY25
GPT Healthcare Limited Investor Presentation – Q4 & FY25 NSE: GPTHEALTH | BSE: 544131
Slide 3: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by GPT Healthcare Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any secur
Slide 4: Table of Content
Table of Content Q4 & FY25 Company Overview Business Highlights Annual Financials Performance 3
Slide 5: Q4 & FY25 Performance
Q4 & FY25 Performance \ = 7 \« LS " ¥ . \
Slide 6: Snapshot of Financial & Operational Performance – Q4 & FY25
Snapshot of Financial & Operational Performance – Q4 & FY25 Revenue from Operations EBITDA & EBITDA Margin PAT & PAT Margin Q4FY25 FY25 Q4FY25 FY25 Q4FY25 FY25 Rs 101.4 Cr Rs 407.1 Cr Rs 22.2 Cr Rs 91.9 Cr Rs 12.8 Cr Rs 50.0 Cr ( 21.6% Margin) ( 22.1% Margin) ( 12.4% Margin) ( 12.0% Margin) Dividend
Slide 7: Financial Highlights – FY25
Financial Highlights – FY25 Net Profit: Rs 50.0 Cr 55% Tax: Rs 19.4 Cr 21% 22% EBITDA : Rs Depreciation: Rs 19.0 Cr 21% 91.9 Cr Finance Costs Rs 3.5 Cr 4% Total Income : Rs 415.6 Cr Medicines and Consumables: 23% 100 % Rs 78.8 Cr __% Employee Benefit Costs : Rs 73.0 Cr 22% Total Expenses: Rs 346.2 C
Slide 8: Road Ahead
Road Ahead Return Ratios • Maintain long term Return on Equity and Return on Capital Employed close to 25% • Confident in maintaining EBITDA Margin of 22.5%+ going ahead and CFO/EBITDA of 80%, consistent with the historical Margins guidance Size • Target to become a 1,000 bed facility in the next 2
Slide 9: Hospital wise Performance – FY25
Hospital wise Performance – FY25 Bed Capacity Revenue Bed Occupancy Rate ARPOB Year of Commissing (No. of Beds) (Rs in Crore) (%) (Rs Per day) 58.1% Salt Lake Hospital 2000 85 70.9 39,236 46.2% Agartala Hospital 2011 205 117.5 33,682 69.0% Dum Dum Hospital 2013 155 161.7 41,183 41.0% Howrah Hospital
Slide 10: Profit & Loss Highlights – Q4 & FY25
Profit & Loss Highlights – Q4 & FY25 Particulars (Rs Cr) Q4FY25 Q4FY24 YoY Q3FY25 QoQ FY25 FY24 YoY Revenue from operations 101.4 99.4 2.0% 102.2 -0.8% 407.1 400.2 1.7% Other Income 1.6 1.6 0.0% 1.9 -15.8% 8.5 5.3 60.4% Total Income 103.0 101.0 2.0% 104.1 -1.1% 415.6 405.5 2.5% Cost of materials con
Slide 11: Key Growth Initiatives
Key Growth Initiatives Continued Investment in Infrastructure New Hospital ✓ Installed cutting-edge robotic surgical Existing Hospitals technology in Salt Lake and Howrah Hospital ✓ Setting up hospitals on Asset-light basis with 500+ robotic surgeries successfully where investment in land and buildi
Slide 12: Company Overview
Company Overview
Slide 13: Key regional corporate healthcare companies in Eastern India
GPT Healthcare – Key regional corporate healthcare companies in Eastern India ✓ Strategically located in Densely Populated Micro Markets of Kolkata and Howrah, Agartala and Raipur ✓ Established Right-Sized, Full-Service Hospitals according to each sub-region, aids High Return on Capital 570 5 Capabi
Slide 14: Salt Lake Hospital (Year 2000)
Salt Lake Hospital (Year 2000) Total 85 Beds, including 17 Beds across ICUs and HDUs along with 3 OTs The Department of Minimal Access Surgery is accredited by National Board of Examinations for training of post-graduate surgeons under the Fellowship of National Board in Minimal Access Surgery Award
Slide 15: Agartala Hospital (Year 2011)
Agartala Hospital (Year 2011) Total 205 Beds, including 66 Beds across ICUs along with 8 OTs & 1 catheterization laboratory The only NABH accredited hospital in Agartala and one among 11 valid accredited hospitals in North-East India as of October 2023. Also accredited by NABL Received the ‘Excellen
Slide 16: Dum Dum Hospital (Year 2013)
Dum Dum Hospital (Year 2013) Total 155 Beds, including 53 Beds across ICUs and HDUs along with 4 OTs & 1 catheterization laboratory NABH accredited and NABL accredited for complying with ISO 15189:2012 standards in the field of medical testing Recognized by the CII for Excellence in Nursing for thei
Slide 17: Howrah Hospital (Year 2019)
Howrah Hospital (Year 2019) Total 116 Beds, including 43 Beds across ICUs and HDUs along with 3 OTs & 1 catheterization laboratory Near Howrah station, the site holds strong potential with no hospital within 5 km Recognized by the CII for Excellence in Nursing for their efforts, commitment and contr
Slide 18: New ILS Raipur Hospital – Commissioned May 2025
New ILS Raipur Hospital – Commissioned on May 2025 Quaternary Care, 158 beds including ICUs & HDUs, 5 OTs, and Oncology facilities. At Pachpedi Naka, Raipur, the facility will serve patients across Raipur, Bilaspur, Durg, and Bhilai. Equipped with 3 Tesla MRI, Cardiac Cath Lab and Dual Source CT Sca
Slide 19: Business Highlights
Business Highlights
Slide 20: Focused on High Return on Capital
Focused on High Return on Capital – Factors that lead to it Strategic Location Disciplined Approach Brand Strength Right Sized, towards Costs demonstrated through of the Hospitals Full Service Payor Mix Being in populous neighbourhoods Operating multispecialty, mid sized Strategic measures towards V
Slide 21: Professional and experienced leadership – Board of Directors
Professional and experienced leadership – Board of Directors Dwarika Prasad Tantia Dr. Om Tantia Anurag Tantia Dr. Aruna Tantia Dr. Ghanshyam Goyal Chairman & Wholetime Director Managing Director Whole-time Director Non - Executive Director Non - Executive Director C C M M M M • Founding member of I
Slide 22: Annual Performance
A} A. Annual Performance
Slide 23: Key Financial Metrics
Key Financial Metrics Revenue from Operations (Rs Cr) EBITDA & EBIDTA Margin PAT & PAT Margin 23.0% 21.8% 23.0% 22.1% 400 12.2% 361 407 11.9% 50 12.0% 337 92 42 39 48 79 80 93 10.6% FY22 FY23 FY24 FY25 FY22 FY23 FY24 FY25 FY22 FY23 FY24 FY25 EBITDA (Rs Cr) EBITDA Margin PAT (Rs Cr) PAT Margin (%) RO
Slide 24: Key Operational Metrics
Key Operational Metrics No. of Beds & Occupancy Rate (%) Average Length of Stay (ALOS) Average Revenue per Occupied Bed (ARPOB) 58.9% 58.9% (in Rs per day) 37,180 56.4% 53.1% 32,947 4.80 556 561 561 561 4.22 3.95 3.54 29,253 29,671 FY22 FY23 FY24 FY25 FY22 FY23 FY24 FY25 FY22 FY23 FY24 FY25 No. of B
Slide 25: Diverse Revenue Mix Across Top 10 Specialties
Diverse Revenue Mix Across Top 10 Specialties Internal Medicine & Diabetology Nepharology General Surgery Critical Care Paediactics Gastroenterology Gynaecology and obstetrics Interventional cardiology Orthopaedics and Joint Replacement Neurosciences Others 10% 10% 12% 18% 19% 3% 19% 4% 5% 6% 6% 7%
Slide 26: Annual Profit & Loss
Annual Profit & Loss Particulars (Rs Cr) FY24 FY25 Revenue from operations 400.2 407.1 Other Income 5.3 8.5 Total Income 405.5 415.6 Cost of materials consumed 83.0 78.8 Employee benefits expense 68.9 73 Other expenses 160.5 171.9 EBITDA 93.1 91.9 EBITDA Margin 23.0% 22.1% Depreciation and amortisat
Slide 27: Balance Sheet
Balance Sheet Assets (Rs Cr) Mar-24 Mar-25 Liabilities (Rs Cr) Mar-24 Mar-25 PPE 201.1 202.6 Share Capital 82.1 82.1 Other Equity 136.4 165.8 Other Non-Current Asset 45.1 46.3 Total Equity 218.5 247.9 Investments 19.2 56.5 Borrowings 3.6 5.5 Non-Current Assets 265.4 305.4 Lease Liabilities 15.3 17.2
Slide 28: Cash Flow Statement
Cash Flow Statement Particulars (in Cr) Mar-24 Mar-25 Cash Flow from Operating Activities Profit before Tax 68.0 69.3 Adjustment from Non-Operating Items Operating Profit before Working Capital 90.0 88.1 (Increase)/decrease in Inventories 0.8 -0.7 (Increase)/decrease in Trade Receivables -5.4 0.6 (I
Slide 29: Stock Information
Stock Information Share Price Movement Shareholding Pattern (as on March 31, 2025) 250 Public 18.6% Promoters DII 65.6% 200 Interim Dividend Final Dividend of Re.1/- 11.4% of Rs. 1.5/- FII 4.5% 150 Price in Rs 100 Promoters FII DII Public Script Related Information (as on 22-May-2025) 50 BSE/NSE Cod
Slide 30: Thank You
Thank ou GPT Healthcare Limited CIN No.: L70101WB1989PLC047402 ghl.cosec@gptgroup.co.in For more details : www.ilshospitals.com